Sydney, Australia (CU)_ Illuccix, a prostate cancer imaging tool developed by Telix Pharmaceuticals (TLX), has been authorized by the US Food and Drug Administration. The product is a kit for making an…

FDA approves Telix Pharmaceuticals’ prostate cancer treatment

What Caused the Miami Plane Crash That Killed Five People on the Ground?

India Faces A BRICS Challenge. Can It Find A Way Through?

Could Healthier Fats Help Men Live Longer After Prostate Cancer?

UK Design Industry Defies AI Replacement Fears as £136.7 Billion Sector Continues to Grow and Redefine the Role of Human Creativity

Germany’s AfD Wins Big in the East – But Falls Just Short of Power

Related Articles

Could Healthier Fats Help Men Live Longer After Prostate Cancer?

Do Younger Brains Really Recover Better Than Older Brains After Traumatic Injury? New Study Says Not So Fast

Why Do Men with the Same Infertility Gene Have Different Fertility Outcomes?

Could Urolithin a From Pomegranates Help Treat Heart Failure? Scientists Discover New Pathway

Could a Wearable Device Help Doctors Track Blood Pressure in ICU Patients?